Ustekinumab is effective against small bowel lesions in Crohn’s disease: two case reports
Autor: | Kentaro Murate, Hiroki Kawashima, Tsunaki Sawada, Kazuhiro Furukawa, Naomi Kakushima, Eizaburo Ohno, Masanao Nakamura, Takashi Honda, Eri Ishikawa, Mitsuhiro Fujishiro, Yasuyuki Mizutani, Masatoshi Ishigami, Takeshi Yamamura, Keiko Maeda |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Crohn's disease medicine.diagnostic_test Endoscope business.industry Gastroenterology Lumen (anatomy) General Medicine Hepatology medicine.disease digestive system diseases Endoscopy 03 medical and health sciences Stenosis 0302 clinical medicine Intestinal mucosa 030220 oncology & carcinogenesis Internal medicine Ustekinumab Medicine 030211 gastroenterology & hepatology business medicine.drug |
Zdroj: | Clinical Journal of Gastroenterology. 14:129-135 |
ISSN: | 1865-7265 1865-7257 |
DOI: | 10.1007/s12328-020-01242-0 |
Popis: | We encountered two patients with Crohn’s disease (CD) for whom induction of ustekinumab was effective for the management of small intestinal lesions with stenosis. The first symptomatic CD case was a 40-year-old female with longitudinal ulcers in the small bowel found at double-balloon endoscopy. She was in a biologic-naive condition. Her symptoms improved immediately after ustekinumab induction. We confirmed the condition of intestinal mucosa by double-balloon endoscopy. Deep ulcers remained open at 24 weeks and were scarred at 72 weeks. The second case was a 50-year-old male who failed to respond to treatment with anti-TNFα agents. The lumen was narrow caused by circumferential ulcer, and an endoscope could not pass the site before induction. The circumferential ulcer had been healed by ustekinumab induction, and an endoscope passed through at 72 weeks. These two cases support the therapeutic efficacy of ustekinumab in alleviating small bowel lesions in CD patients. |
Databáze: | OpenAIRE |
Externí odkaz: |